The U.S. Food & Drug Administration ensure the nation’s prescription drugs, medical drug, and food products are safe for consumers and patients.
Comments on CMS-3295-P by the Alliance
Published August 15, 2016
The Alliance for Aging Research submitted comments to the Centers for Medicare and Medicaid Services (CMS) on its proposed rule: CMS-3295-P, Medicare and Medicaid Programs; Hospital and Critical Access Hospital (CAH) Changes to Promote Innovation, Flexibility, and Improvement in Patient Care. The Alliance’s comments focused on quality assessment and reporting, antibiotic stewardship requirements, and infection prevention standards in the proposed rule that advance the priorities of the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB).